Acute Leukemias: Clinical Trials

3 trials for Acute Leukemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Unknown 1, Withdrawn 1
Phase 11Unknown 1

Follow Acute Leukemias: new trials by email Literature Review of Acute Leukemias trials Research Report on Acute Leukemias

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia
LDE225 - Acute Leukemias
Phase 2CompletedNovartis Pharmaceuticals702013-05-012016-08-30
Providing Access to Cord Blood Units for Transplants
Access to unlicensed cord blood units - Chronic Myelogous Leukemia/Other Leukemia, Acute Leukemias
Phase 2WithdrawnNational Cancer Institute (NCI)2011-10-272018-12-21
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells
Transplantation of CD3/CD19 depleted stem cells - Acute Leukemias, Aplastic Anemia
Phase 1 / Phase 2UnknownUniversity Children's Hospital Tuebingen1202004-03-012014-10-08

Narrower conditions

Leukemia (2)  ·  Anemia, Aplastic (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lysosomal Storage Diseases (1)  ·  Multiple Myeloma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)  ·  Thalassemia (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Anemia (2)  ·  Bone Marrow Diseases (2)  ·  Disease Attributes (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Myeloid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Anemia, Hemolytic (1)

Interventions

sonidegib (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  Novartis Pharmaceuticals (1)  ·  University Children's Hospital Tuebingen (1)

Countries

Austria (2)  ·  Germany (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Peter Lang, MD (1)  ·  Ronald E Gress, M.D. (1)